Literature DB >> 24271241

The action of fenfluramine andp-chloramphetamine on serotonergic mechanisms: A comparative study in rat brain nuclei.

L M Neckers1, L Bertilsson, E Costa.   

Abstract

A single injection of fenfluramine orp-chloroamphetamine (PCA) (100 μmol/kg intraperitoneally) decreases the serotonin (5HT) content and the tryptophan hydroxylase activity in various areas of the rat brain. Other reports have shown that a single injection of fenfluramine or PCA causes cytopathological changes in a serotonergic midbrain nucleus which was termed B9 by Dahlstrom and Fuxe (1). Despite this cytopathological change, fenfluramine fails to reduce the tryptophan hydroxylase activity in B9. In hippocampus the decrease of tryptophan hydroxylase elicited by fenfluramine persists for less than 21 days; in contrast PCA reduces the tryptophan hydroxylase activity in hippocampus, striatum, septal nuclei and B9 for longer than 21 days. Probably the decrease of tryptophan hydroxylase elicited by PCA in B9 is due to retrograde degeneration; the intensity and duration of the biochemical lesion elicited by fenfluramine and PCA in serotonergic terminals are a factor in determining the extent of the biochemical lesion in serotonergic cell bodies.

Entities:  

Year:  1976        PMID: 24271241     DOI: 10.1007/BF00965628

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  12 in total

1.  5-Hydroxytryptamine depletion in mesencephalic nuclei of rat brain following a single injection of p-chloroamphetamine.

Authors:  L Bertilsson; S H Koslow; E Costa
Journal:  Brain Res       Date:  1975-06-27       Impact factor: 3.252

2.  Measurement of tryptophan hydroxylase in single brain nuclei by high pressure liquid chromatography.

Authors:  J L Meek; L M Neckers
Journal:  Brain Res       Date:  1975-06-27       Impact factor: 3.252

3.  CHLORINATED ARYLALKYLAMINES AFFECTING THE CEREBRAL METABOLISM OF 5-HYDROXYTRYPTAMINE.

Authors:  A PLETSCHER; G BARTHOLINI; H BRUDERER; W P BURKARD; K F GEY
Journal:  J Pharmacol Exp Ther       Date:  1964-09       Impact factor: 4.030

4.  Mass fragmentographic measurement of norepinephrine dopamine, serotonin and acetylcholine in seven discrete nuclei of the rat tel-diencephalon.

Authors:  S H Koslow; G Racagni; E Costa
Journal:  Neuropharmacology       Date:  1974-12       Impact factor: 5.250

5.  Gas chromatographic-mass spectrometric assay of four indole alkylamines of rat pineal.

Authors:  F Cattabeni; S H Koslow; E Costa
Journal:  Science       Date:  1972-10-13       Impact factor: 47.728

6.  Reduction of tryptophan hydroxylase activity and 5-hydroxytryptamine concentration in certain rat brain nuclei after p-chloroamphetamine.

Authors:  L M Neckers; L Bertilsson; S H Koslow; J L Meek
Journal:  J Pharmacol Exp Ther       Date:  1976-02       Impact factor: 4.030

7.  Fenfluramine: evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin.

Authors:  J A Harvey; S E McMaster
Journal:  Psychopharmacol Commun       Date:  1975

8.  Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms.

Authors:  E Sanders-Bush; J A Bushing; F Sulser
Journal:  J Pharmacol Exp Ther       Date:  1975-01       Impact factor: 4.030

9.  P-Chloramphetamine: Selective neurotoxic action in brain.

Authors:  J A Harvey; S E McMaster; L M Yunger
Journal:  Science       Date:  1975-03-07       Impact factor: 47.728

10.  Action of fenfluramine on monoamine stores of rat tissues.

Authors:  E Costa; A Groppetti; A Revuelta
Journal:  Br J Pharmacol       Date:  1971-01       Impact factor: 8.739

View more
  3 in total

1.  High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.

Authors:  P M Whitaker; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

2.  Effect of fenfluramine administration on synaptosomal uptake of some neurotransmitters and on synaptosomal enzymes which metabolise GABA.

Authors:  J C Kouyoumdjiian; P Gonnard; M F Belin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

Review 3.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors:  A R Green; A J Cross; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.